{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:21:28Z","timestamp":1791858088751,"version":"4.3.4"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2016-12M-2-004"],"award-info":[{"award-number":["2016-12M-2-004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470937, 81641024"],"award-info":[{"award-number":["81470937, 81641024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital Specialized Clinical Application Project","award":["Z121107001012139"],"award-info":[{"award-number":["Z121107001012139"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180811","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T13:43:31Z","timestamp":1499694211000},"page":"e0180811","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome"],"prefix":"10.1371","volume":"12","author":[{"given":"Xiaoyan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"91","author":"A Blanchard","year":"2017","journal-title":"Kidney Int"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00467-011-1871-4","article-title":"Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects","volume":"26","author":"HW Seyberth","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/0272-6386(95)90563-4","article-title":"Normal Prostaglandinuria E2 in Gitelman\u2019s Syndrome, the Hypocalciuric Variant of Bartter's Syndrome","volume":"25","author":"C Luthy","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/ckj\/sfu029","article-title":"A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin","volume":"7","author":"N Larkins","year":"2014","journal-title":"Clinical kidney journal"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/adc.81.6.508","article-title":"Dose related growth response to indometacin in Gitelman syndrome","volume":"81","author":"LC Liaw","year":"1999","journal-title":"Arch Dis Child"},{"issue":"8","key":"ref6","first-page":"650","article-title":"A clinical analysis of 9 cases of Gitelman syndrome","volume":"45","author":"GQ Yang","year":"2006","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/08860220802212718","article-title":"Analyses of subjects with hypokalemic metabolic alkolosis, Gitelman's and Bartter's syndrome","volume":"30","author":"Y Onem","year":"2008","journal-title":"Ren Fail"},{"issue":"5","key":"ref8","first-page":"617","article-title":"Gitelman syndrome with mental retardation: a case report","volume":"23","author":"GA Tuhta","year":"2010","journal-title":"Journal of nephrology"},{"issue":"3","key":"ref9","first-page":"432","article-title":"Clinical analysis of 17 cases of Gitelman syndrome","volume":"32","author":"L Qu","year":"2012","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.semerg.2013.03.003","article-title":"Casual diagnosis of Gitelman's syndrome","volume":"40","author":"V Martin-Miguel","year":"2014","journal-title":"Semergen"},{"key":"ref11","article-title":"Clinical and Genetic Spectrum of Bartter Syndrome Type 3","author":"E Seys","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1681\/ASN.2014030293","article-title":"Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome","volume":"26","author":"A Blanchard","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.krcp.2015.10.004","article-title":"Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney","volume":"34","author":"R Norregaard","year":"2015","journal-title":"Kidney Res Clin Pract"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"e0159804","DOI":"10.1371\/journal.pone.0159804","article-title":"Prostaglandin-E2 Mediated Increase in Calcium and Phosphate Excretion in a Mouse Model of Distal Nephron Salt Wasting","volume":"11","author":"M Soleimani","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4158\/EP14432.OR","article-title":"Normomagnesemic Gitelman syndrome patients exhibit a stronger reaction to thiazide than hypomagnesemic patients","volume":"21","author":"L Jiang","year":"2015","journal-title":"Endocr Pract"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"E1478","DOI":"10.1210\/jc.2012-1707","article-title":"Genotype, phenotype, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation","volume":"97","author":"MH Tseng","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000360773","article-title":"Clinical Severity of Gitelman Syndrome Determined by Serum Magnesium","volume":"39","author":"L Jiang","year":"2014","journal-title":"Am J Nephrol"},{"issue":"3","key":"ref18","first-page":"275","article-title":"Value of Chloride Clearance Test in Differential Diagnosis of Gitelman Syndrome","volume":"38","author":"X Peng","year":"2016","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"R782","DOI":"10.1152\/ajpregu.00600.2004","article-title":"Salt handling in the distal nephron: lessons learned from inherited human disorders","volume":"288","author":"N Jeck","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"ref20","first-page":"432","article-title":"Clinical analysis of 17 cases of Gitelman syndrome","volume":"32","author":"L Qu","year":"2012","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref21","article-title":"Mutation profile and treatment of Gitelman syndrome in Chinese patients","author":"F Wang","year":"2016","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1203\/01.PDR.0000101747.09626.6B","article-title":"Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies","volume":"55","author":"M Komhoff","year":"2004","journal-title":"Pediatr Res"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9343(01)01086-5","article-title":"Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies","volume":"112","author":"M Peters","year":"2002","journal-title":"Am J Med"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5662\/wjm.v5.i2.55","article-title":"Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations","volume":"5","author":"A Al Shibli","year":"2015","journal-title":"World J Methodol"},{"issue":"8059","key":"ref25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(78)90110-1","article-title":"Raised urinary prostaglandins in patient without Bartter's syndrome","volume":"1","author":"H Nivet","year":"1978","journal-title":"Lancet"},{"key":"ref26","article-title":"Salt-Losing Nephropathy in Mice with a Null Mutation of the Clcnk2 Gene","author":"A Grill","year":"2016","journal-title":"Acta physiologica (Oxford, England)"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/MIB.0000000000000062","article-title":"Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis","volume":"20","author":"Y Arai","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1046\/j.1523-1755.2001.00988.x","article-title":"Inhibition of COX-2 counteracts the effects of diuretics in rats","volume":"60","author":"MC Kammerl","year":"2001","journal-title":"Kidney Int"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/labinvest.2015.79","article-title":"Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors","volume":"95","author":"R Nasrallah","year":"2015","journal-title":"Lab Invest"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00467-015-3143-1","article-title":"Pathophysiology and clinical presentations of salt-losing tubulopathies","volume":"31","author":"HW Seyberth","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"F214","DOI":"10.1152\/ajprenal.00327.2013","article-title":"Biomechanical regulation of cyclooxygenase-2 in the renal collecting duct","volume":"306","author":"Y Liu","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.ki.5001627","article-title":"Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats","volume":"70","author":"Y Kaneshiro","year":"2006","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"396209","DOI":"10.4061\/2011\/396209","article-title":"Primary molecular disorders and secondary biological adaptations in bartter syndrome","volume":"2011","author":"G Deschenes","year":"2011","journal-title":"Int J Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2369-11-28","article-title":"Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels","volume":"11","author":"TG Lauridsen","year":"2010","journal-title":"BMC Nephrol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ki.1981.12","article-title":"Prostaglandins and Bartter's syndrome","volume":"19","author":"MJ Dunn","year":"1981","journal-title":"Kidney Int"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00424-012-1130-y","article-title":"Metabolic control of renin secretion","volume":"465","author":"J Peti-Peterdi","year":"2013","journal-title":"Pflugers Arch"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"e0118004","DOI":"10.1371\/journal.pone.0118004","article-title":"Urinary prostaglandin E2 metabolite and pancreatic cancer risk: case-control study in urban Shanghai","volume":"10","author":"J Zhao","year":"2015","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T05:27:35Z","timestamp":1569734855000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180811"}},"subtitle":[],"editor":[{"given":"Zhanjun","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180811","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}